AHPPI Winter Meeting 2010
Current Advances in the Development of Vaccines and Biopharmaceuticals: A Challenge not be Sneezed at?
4 February 2010
St George’s Hospital, Tooting.
Hosted by Richmond Pharmacology.
The Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI) is proud to announce the AHPPI Annual Winter Meeting, taking place in February this year. The AHPPI is an informal cross-industry discussion group whose purpose is to address issues facing those involved in early phase drug development and to educate members through directed symposia at each of its 2 meetings per year.
This year’s AHPPI Annual Winter meeting will be hosted at St George’s Hospital, University of London, Tooting and will take place on 4th February 2010.
This meeting has recently been awarded 3 CPD points by the Faculty of Pharmaceutical Physicians
Meeting Programme: |
 |
|
12h30 - 12h50 > |
Registration | |
12h55 > |
Opening remarks, Dr Ulrike Lorch, Richmond Pharmacology | |
| Chair: Dr Peter Dewland, PDC Ltd. | ||
13h00 - 13h25 > |
Development of HIV vaccine, Professor David Lewis, St George’s Vaccine Institute | |
13h25 - 13h50 > |
H1N1 vaccine, Professor John Oxford, Retroscreen Virology Ltd | |
13h50 - 14h15 > |
Development of a vaccine against MRSA infections, Dr Afshan Ahmad, Vaccine Research International | |
14h15 - 14h30 > |
Question time | |
14h30 - 15h00 > |
Tea | |
| Chair: Dr Simon Constable, ICON Development Solutions | ||
15h00 - 15h25 > |
Challenges of vaccine development, Andrew Nolan, Quintiles | |
15h25 - 15h50 > |
Current status of HPV vaccines and associated R&D, Dr Simon Beddows, Health Protection Agency | |
15h50 - 16h15 > |
Shingles vaccination - preventing reactivation of a dormant virus? Dr Azharul Mannan, Sanofi Pasteur MSD | |
16h15 - 16h40 > |
Positive and Negative Aspects of Immunogenicity, Professor Geoff Hale, BioAnaLab | |
16h40 - 16h55 > |
Question time | |
17h00 > |
Meeting close, Dr Nicole Calder, Merck & Co. | |
Drinks Reception, Boardroom 3, Hunter Wing |
||